Roche Molecular Systems Director of Business Development Salaries in Dalton, GA
The average Roche Molecular Systems Director of Business Development in Dalton, GA earns an estimated $216,423 annually, which includes an estimated base salary of $166,676 with a $49,747 bonus. Roche Molecular Systems' Director of Business Development compensation is $50,121 more than the US average for a Director of Business Development. Director of Business Development salaries at Roche Molecular Systems in Dalton, GA can range from $73,000 - $390,000.
In Dalton, GA, The Business Development Department at Roche Molecular Systems earns $11,653 more on average than the Marketing Department.
Last updated a year ago.
- $166,676
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at Roche Molecular Systems
In Dalton, GA, Directors of Business Development earn $3,742 more than Directors of Business Development.
Compensation at Roche Molecular Systems by Department
In Dalton, GA, The Business Development Department averages $11,653 more than the Marketing Department, and $416 less than the Engineering Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Roche Molecular Systems reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Roche Molecular Systems reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Roche Molecular Systems Rate Their Compensation
The majority of Directors of Business Development at Roche Molecular Systems believe they're compensated fairly. 100% of Directors of Business Development at Roche Molecular Systems say they receive annual bonuses, and the majority (60%) are satisfied with their benefits. See more compensation ratings at Roche Molecular Systems
